Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus ketamine with propofol for outpatient colonoscopy sedation
IRCT20220706055402N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, propofol and ketamine in None (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Sedation rate, Hemodynamic instability and 1 more. Started Jul 2022; status: completed.
02
Drugs
dexmedetomidinepropofolketamine
Beyond the preview
Go deeper on IRCT20220706055402N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220706055402N1.